Literature DB >> 17021265

Increased apoptosis in cystinotic fibroblasts and renal proximal tubule epithelial cells results from cysteinylation of protein kinase Cdelta.

Margaret A Park1, Vojislav Pejovic, Kathryn G Kerisit, Sacha Junius, Jess G Thoene.   

Abstract

Cystinosis is a rare genetic disease characterized by defective lysosomal cystine transport and increased lysosomal cystine. How lysosomal cystine causes the lethal nephropathic phenotype is unknown. It was shown recently that cultured fibroblasts and renal proximal tubule epithelial cells whose lysosomes are cystine-loaded display a two-fold or greater increase in apoptosis after both intrinsic and extrinsic stimuli. The mechanism for the increased apoptosis is unknown. Protein kinase Cdelta (PKCdelta) is a proapoptotic protein kinase that has been shown in vitro to be activated via cysteinylation. This report now shows that PKCdelta forms disulfide bonds specifically with cystine that is released from lysosomes in cultured fibroblasts and renal proximal tubule epithelial cells during apoptosis. PKCdelta in cystinotic fibroblasts and renal proximal tubule epithelial cells have a four- to six-fold greater association with its substrate, lamin B, and a 2.5-fold increase in specific activity after TNF-alpha exposure. Both RNA inhibition and chemical inhibition of PKCdelta resulted in a significant decrease in apoptosis in cystinotic cells but not in normal cells. It is proposed that abnormally increased apoptosis plays a role in evolution of the cystinotic phenotype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17021265     DOI: 10.1681/ASN.2006050474

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  28 in total

Review 1.  Mitochondrial energetics and therapeutics.

Authors:  Douglas C Wallace; Weiwei Fan; Vincent Procaccio
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

2.  Cystine accumulation attenuates insulin release from the pancreatic β-cell due to elevated oxidative stress and decreased ATP levels.

Authors:  Bernadette McEvoy; Rodolfo Sumayao; Craig Slattery; Tara McMorrow; Philip Newsholme
Journal:  J Physiol       Date:  2015-11-18       Impact factor: 5.182

3.  Cell-Based Phenotypic Drug Screening Identifies Luteolin as Candidate Therapeutic for Nephropathic Cystinosis.

Authors:  Ester De Leo; Mohamed A Elmonem; Sante Princiero Berlingerio; Marine Berquez; Beatrice Paola Festa; Roberto Raso; Francesco Bellomo; Tobias Starborg; Manoe Jacoba Janssen; Zeinab Abbaszadeh; Sara Cairoli; Bianca Maria Goffredo; Rosalinde Masereeuw; Olivier Devuyst; Martin Lowe; Elena Levtchenko; Alessandro Luciani; Francesco Emma; Laura Rita Rega
Journal:  J Am Soc Nephrol       Date:  2020-06-05       Impact factor: 10.121

4.  Insights into novel cellular injury mechanisms by gene expression profiling in nephropathic cystinosis.

Authors:  Poonam Sansanwal; Li Li; Szu-Chuan Hsieh; Minnie M Sarwal
Journal:  J Inherit Metab Dis       Date:  2010-09-24       Impact factor: 4.982

Review 5.  Lysosome dysfunction in the pathogenesis of kidney diseases.

Authors:  Kameswaran Surendran; Seasson P Vitiello; David A Pearce
Journal:  Pediatr Nephrol       Date:  2013-11-12       Impact factor: 3.714

6.  Mitochondrial autophagy promotes cellular injury in nephropathic cystinosis.

Authors:  Poonam Sansanwal; Benedict Yen; William A Gahl; Yewei Ma; Lihua Ying; Lee-Jun C Wong; Minnie M Sarwal
Journal:  J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 10.121

7.  Caspase-4 may play a role in loss of proximal tubules and renal injury in nephropathic cystinosis.

Authors:  Poonam Sansanwal; Neeraja Kambham; Minnie M Sarwal
Journal:  Pediatr Nephrol       Date:  2010-01       Impact factor: 3.714

Review 8.  Cell models for studying renal physiology.

Authors:  M Bens; A Vandewalle
Journal:  Pflugers Arch       Date:  2008-04-22       Impact factor: 3.657

9.  Use of Human Induced Pluripotent Stem Cells and Kidney Organoids To Develop a Cysteamine/mTOR Inhibition Combination Therapy for Cystinosis.

Authors:  Jennifer A Hollywood; Aneta Przepiorski; Randall F D'Souza; Sreevalsan Sreebhavan; Ernst J Wolvetang; Patrick T Harrison; Alan J Davidson; Teresa M Holm
Journal:  J Am Soc Nephrol       Date:  2020-03-20       Impact factor: 10.121

10.  Cysteamine prevents inhibition of thiol-containing enzymes caused by cystine or cystine dimethylester loading in rat brain cortex.

Authors:  Virginia Cielo Rech; Luciane Rosa Feksa; Rochele Marisa Müller Fleck; Genaro Azambuja Athaydes; Paula Karina Barcelos Dornelles; Valnes Rodrigues-Junior; Clovis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2008-04-17       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.